Revvity, Inc. RVTY

Updated: 6 Sep 2026

NYSE | Biotech | Life sciences and diagnostics

No signal published yet

We already track Revvity and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Revvity free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Life sciences and diagnostics

Market sentiment

Sentiment has modestly improved following the FDA news; commentary is mainly focused on the product catalyst and Q1 execution, while the stock has remained volatile without clear signs of extreme risk-on/risk-off positioning.

We're already tracking Revvity, Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, Revvity reported its second quarter 2026 financial results, generating $730 million in revenue and raising its full-year pro forma guidance. In conjunction with the earnings report, the company announced a definitive agreement to divest its China immunodiagnostics business.

What Firelda Watch includes for Revvity, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Revvity, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Medicover
MCOV B
HOLD
Vimian Group AB (publ)
VIMIAN
HOLD
CellaVision AB (publ)
CEVI
HOLD
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD

Biotech

More companies in this sector

Want to follow Revvity, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Revvity free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Revvity, Inc. RVTY
Revvity — follow and we'll monitor it
Follow Revvity free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.